Read the 1 mg table before the forum
Decreased libido 1.8% versus 1.3%, ED 1.3% versus 0.7%, ejaculation disorder 1.2% versus 0.7%. Discontinuation for those events: 1.2% versus 0.9%.
Resolution happened in many men who stopped and in many who continued. By year five, each of those sexual cells had fallen to 0.3% or less in the labelled follow-up note.
That is the opposite of 'everyone loses function' and the opposite of 'it never happens'. Brynza will not pick a tribe.
| Year-1 drug-related | Finasteride 1 mg | Placebo |
|---|---|---|
| Decreased libido | 1.8% | 1.3% |
| Erectile dysfunction | 1.3% | 0.7% |
| Ejaculation disorder | 1.2% | 0.7% |
| Any of those | 3.8% | 2.1% |
A few extra men per hundred, not fifty
Year one: 3.8% versus 2.1% for any sexual cluster. Discontinuation 1.2% versus 0.9%.
Resolution in many who stopped and many who continued. By year five each cell fell to 0.3% or less in the labelled follow-up.
Semen volume can drop about 0.3 mL in a 48-week note.
Post-marketing persistence cannot be well estimated. Still a reason to examine, not to restart 1 mg as a home test.
Depression and suicidal ideation are on the sheet. Hair is not a hostage. 112 if unsafe.
Breast lump, pain, discharge: examine. Tenderness under 1% still gets a visit if there is a lump.
Do not start three PDE5 drugs from a drawer. Do not double to 2 mg because sides did not happen.
Talk early. Silence for a year tangles fear and the 1.3% cell.
Three quiet months after stop still deserve a visit
Persistence is in post-marketing. Frequency unknown. Get examined. Do not restart 1 mg as a test without a clinician. Do not stack leftover sildenafil 25 mg as a verdict. Mood on month two with better hair is still a stop-and-be-seen sentence. Hair is not a reason to stay. If unsafe, 112.
Year-five shrinkage of the trial cells does not erase a man who is still softer at month three. Both sentences can be true. This desk will not join a tribe. Bring the stop date, the start date, and any PDE5 leftovers.
PSA talk still belongs at the GP. A lower PSA on 1 mg is expected. Do not skip the prostate sentence because the AE talk got loud.
Parent: finasteride column. INN sister page for export fonts. This page stays on the table and the mood line.
The label now says 'may continue after stop'
Post-marketing language includes sexual dysfunction that continued after discontinuation, poor semen quality (sometimes improved after stop), testicular pain, hematospermia.
That paragraph is why a calm stop-and-review is reasonable if function falls and stays down. It is not a proof that every man is ruined. Frequency cannot be well estimated from spontaneous reports.
Semen volume can drop a little (about 0.3 mL in a 48-week note). That is a labelled measurement, not folklore.
The later cells shrank in the labelled follow-up
By year five, each sexual cell had fallen to 0.3% or less in the labelled note. That is not a promise your month-two ED will vanish. It is a reason not to treat year one as a life sentence from a single post.
Resolution happened in many who stopped and in many who continued. Both sentences are on the sheet.
Semen volume can drop about 0.3 mL in a 48-week measurement. That is a labelled number, not folklore.
Post-marketing persistence cannot be well estimated. It is still a reason to examine, not to restart 1 mg as a home test.
Doubling to 2 mg because sides 'did not happen' is not the lock. More milligrams is a dare.
Three PDE5 drugs from a drawer is not a 1.3% management plan.
A lump under 1 percent still gets a visit
Breast lump, pain, or discharge: examine. Tenderness under 1% in the old tables still gets a visit if there is a lump. Rare male breast cancer sits in post-marketing. Do not wait for a forum vote. Year-one sexual cluster 3.8% versus 2.1% and discontinuation 1.2% versus 0.9% remain the trial sentences. Year-five cells shrank to 0.3% or less in labelled follow-up. Post-marketing persistence cannot be well estimated. Still a reason to examine, not to restart 1 mg as a home test.
Depression and suicidal ideation are on the sheet. Hair is not a hostage. 112 if unsafe. Partners who like the hair while mood falls should say the mood sentence first. Do not start three PDE5 drugs from a drawer. Do not double to 2 mg because sides did not happen. Talk early. Silence for a year tangles fear and the 1.3% cell. Semen volume can drop about 0.3 mL in a 48-week note. That is a few extra men per hundred, not fifty, and not never.
Three quiet months after stop still deserve hormones, mood, and vascular looked at. Do not stack leftover sildenafil 25 mg as a verdict. Women who can be pregnant still should not handle dust while you debate sides. PSA still belongs at the GP. A lower PSA on 1 mg is expected. Do not skip the prostate sentence because the AE talk got loud.
Parent: finasteride column. INN sister page for export fonts. Lock remains 1 mg. Small percentages still deserve a sentence.
Depression is on the sheet
Nervous-system post-marketing: depression, suicidal ideation and behavior. EU texts tell clinicians to watch mood and to consider stopping if it appears.
Sexual AE and mood can feed each other. That does not make the psychiatric line 'just anxiety about hair'. Ask. Stop. Get help. 112 if you are not safe.
No tribe, both sentences
Not everyone gets ED. Not never happens. Brynza will not pick a forum tribe.
If 1 mg is helping and the table is quiet, that is allowed.
If function falls and stays down after stop, get hormones, mood, vascular looked at.
Partners who see hair improve while mood falls should say so.
Women who can be pregnant still should not handle dust while you debate sides.
INN map is the sister page. This page is the percentages.
Parent: finasteride column.
What not to do with a 1.3% cell
Do not start three PDE5 drugs from a drawer. Do not double 1 mg to 'get the hair faster' when you are already scared of AEs.
Do not stay silent for a year. Early talk is how you separate the 1.3% from performance fear.
Women who can be pregnant still should not handle dust. That stays true while you debate sides.
- Mood change - stop and contact a clinician
- Breast lump - examine, do not wait for a hair cycle
- Persistent ED after stop - urology/psych as needed, not a megadose restart
- Do not split 5 mg to chase hair while scared of 1 mg
Tenderness is uncommon; lumps are a visit
Breast tenderness or enlargement occurred in under 1% in some 1 mg summaries. Post-marketing includes male breast cancer reports. Lumps, pain, or nipple discharge get examined.
Gynecomastia is not proof of a hidden 5 mg. It is a reason to be seen.
Silence for a year is how fear and the 1.3% tangle
Early talk separates the labelled increment from performance fear. Both can be true in the same man.
Partners who watch hair improve while mood falls should say so. Hair is not a hostage.
Breast tenderness under 1% still gets examined if there is a lump or discharge. Rare cancer reports exist.
If you are trying to conceive, say so. Semen quality notes are post-marketing; some improved after stop.
112 if you are not safe. The psychiatric line is not 'just anxiety about hair'.
Women who can be pregnant still should not handle dust while you debate sides.
Year-five cells shrank; post-marketing did not vanish
Year one: 3.8% versus 2.1% for any sexual cluster. Discontinuation 1.2% versus 0.9%. Resolution in many who stopped and many who continued. By year five each labelled follow-up cell fell to 0.3% or less. Semen volume can drop about 0.3 mL in a 48-week note. That is a few extra men per hundred, not fifty. It is also not never. Post-marketing persistence cannot be well estimated. Still a reason to examine, not to restart 1 mg as a home test.
Depression and suicidal ideation are on the sheet. Hair is not a hostage. 112 if unsafe. Partners who see hair improve while mood falls should say so. Breast lump, pain, discharge: examine. Tenderness under 1% still gets a visit if there is a lump. Do not start three PDE5 drugs from a drawer. Do not double to 2 mg because sides did not happen. Talk early. Silence for a year tangles fear and the 1.3% cell.
Not everyone gets ED. Not never happens. Brynza will not pick a forum tribe. If 1 mg is helping and the table is quiet, that is allowed. If function falls and stays down after stop, get hormones, mood, and vascular looked at. Women who can be pregnant still should not handle dust while you debate sides. INN map is the sister page. This page is the percentages.
A man too scared to start after Reddit can say the fear before he starts. A few extra men per hundred reported a sexual AE in year one; most did not; we still stop if it happens to you. The prescriber can wait. Parent: finasteride column. Lock remains 1 mg.
Small percentages still deserve a sentence
If 1 mg is helping hair and the table is quiet, that is allowed. If mood or function falls, the hair is not a hostage.
INN map: Finpecia INN. Parent: finasteride column.
Sources
- Propecia PI Table 1 year 1 percentages; discontinuation 1.2% vs 0.9%
- Incidence of each sexual AE decreased to ≤0.3% by year 5 in the labelled note
- Post-marketing: persistence after stop, depression, suicidal ideation, breast changes
Checked against the current label and reviewed by Dr. Tomasz Krajewski. See Brief, Set, Proof, Issue.